These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Impact of contrast-induced acute kidney injury definition on clinical outcomes. Budano C; Levis M; D'Amico M; Usmiani T; Fava A; Sbarra P; Burdese M; Segoloni GP; Colombo A; Marra S Am Heart J; 2011 May; 161(5):963-71. PubMed ID: 21570530 [TBL] [Abstract][Full Text] [Related]
4. Contrast-induced acute kidney injury following coronary angiography: a cohort study of hospitalized patients with or without chronic kidney disease. Neyra JA; Shah S; Mooney R; Jacobsen G; Yee J; Novak JE Nephrol Dial Transplant; 2013 Jun; 28(6):1463-71. PubMed ID: 23585585 [TBL] [Abstract][Full Text] [Related]
5. Short-Term High-Dose Vitamin E to Prevent Contrast Medium-Induced Acute Kidney Injury in Patients With Chronic Kidney Disease Undergoing Elective Coronary Angiography: A Randomized Placebo-Controlled Trial. Rezaei Y; Khademvatani K; Rahimi B; Khoshfetrat M; Arjmand N; Seyyed-Mohammadzad MH J Am Heart Assoc; 2016 Mar; 5(3):e002919. PubMed ID: 27068631 [TBL] [Abstract][Full Text] [Related]
6. A single cystatin C determination before coronary angiography can predict short and long-term adverse events. Budano C; Andreis A; De Filippo O; Bissolino A; Lanfranco G; Usmiani T; Gai M; Levis M; Bergamasco L; Marra S; Rinaldi M; Ferrari GM Int J Cardiol; 2020 Feb; 300():73-79. PubMed ID: 31619362 [TBL] [Abstract][Full Text] [Related]
7. Combined impact of chronic kidney disease and contrast-induced nephropathy on long-term outcomes in patients with ST-segment elevation acute myocardial infarction who undergo primary percutaneous coronary intervention. Nakahashi H; Kosuge M; Sakamaki K; Kiyokuni M; Ebina T; Hibi K; Tsukahara K; Iwahashi N; Kuji S; Oba MS; Umemura S; Kimura K Heart Vessels; 2017 Jan; 32(1):22-29. PubMed ID: 27106917 [TBL] [Abstract][Full Text] [Related]
8. Statins and contrast-induced acute kidney injury with coronary angiography. Gandhi S; Mosleh W; Abdel-Qadir H; Farkouh ME Am J Med; 2014 Oct; 127(10):987-1000. PubMed ID: 24852935 [TBL] [Abstract][Full Text] [Related]
9. [Contrast-induced acute kidney injury after primary percutaneous coronary interventions: Prevalence, predictive factors, and outcomes]. Kobalava ZD; Villevalde SV; Gaskina AA; Mayskov VV; Moiseev VS Ter Arkh; 2015; 87(6):50-55. PubMed ID: 26281196 [TBL] [Abstract][Full Text] [Related]
10. Increased plasma osmolar gap is predictive of contrast-induced acute kidney injury. Kim S; Sung J; Kang WC; Ahn SY; Kim DK; Chin HJ; Na KY; Joo KW; Chae DW; Han JS Tohoku J Exp Med; 2012 Oct; 228(2):109-17. PubMed ID: 22976551 [TBL] [Abstract][Full Text] [Related]
11. Effect of renin-angiotensin-system blockers on contrast-medium-induced acute kidney injury after coronary angiography. Goo JJ; Kim JJ; Kang JH; Kim KN; Byun KS; Kim MK; Kim TI Korean J Intern Med; 2014 Mar; 29(2):203-9. PubMed ID: 24648803 [TBL] [Abstract][Full Text] [Related]
12. Association of contrast-induced acute kidney injury with long-term cardiovascular events in acute coronary syndrome patients with chronic kidney disease undergoing emergent percutaneous coronary intervention. Watabe H; Sato A; Hoshi T; Takeyasu N; Abe D; Akiyama D; Kakefuda Y; Nishina H; Noguchi Y; Aonuma K Int J Cardiol; 2014 Jun; 174(1):57-63. PubMed ID: 24726211 [TBL] [Abstract][Full Text] [Related]
13. Predictors of outcomes of contrast-induced acute kidney injury after percutaneous coronary intervention in patients with chronic kidney disease. Kim JH; Yang JH; Choi SH; Song YB; Hahn JY; Choi JH; Lee SH; Gwon HC Am J Cardiol; 2014 Dec; 114(12):1830-5. PubMed ID: 25438909 [TBL] [Abstract][Full Text] [Related]
14. Longitudinal Risk of Adverse Events in Patients With Acute Kidney Injury After Percutaneous Coronary Intervention: Insights From the National Cardiovascular Data Registry. Valle JA; McCoy LA; Maddox TM; Rumsfeld JS; Ho PM; Casserly IP; Nallamothu BK; Roe MT; Tsai TT; Messenger JC Circ Cardiovasc Interv; 2017 Apr; 10(4):. PubMed ID: 28404621 [TBL] [Abstract][Full Text] [Related]
15. Effects of probucol on contrast-induced acute kidney injury in patients undergoing percutaneous coronary intervention. Wang Y; Shi Y; Xu X; Ge W; Yang S; Lu C Medicine (Baltimore); 2019 Jun; 98(25):e16049. PubMed ID: 31232940 [TBL] [Abstract][Full Text] [Related]
16. [Effects of Dapagliflozin on contrast-induced acute kidney injury in patients with type 2 diabetes mellitus underwent percutaneous coronary intervention]. Yang SC; Ma YF; Zhang P; Cong HL; Fu NK Zhonghua Yi Xue Za Zhi; 2024 Jun; 104(22):2059-2065. PubMed ID: 38858216 [No Abstract] [Full Text] [Related]
17. Elevated homocysteine and the risk of contrast-induced nephropathy: a cohort study. Barbieri L; Verdoia M; Schaffer A; Niccoli G; Perrone-Filardi P; Bellomo G; Marino P; Suryapranata H; Luca GD Angiology; 2015 Apr; 66(4):333-8. PubMed ID: 24830422 [TBL] [Abstract][Full Text] [Related]
18. Effect of the Mehran risk score for the prediction of clinical outcomes after percutaneous coronary intervention. Sato A; Hoshi T; Kakefuda Y; Harunari T; Watabe H; Hiraya D; Akiyama D; Abe D; Takeyasu N; Aonuma K J Cardiol; 2015 Nov; 66(5):417-22. PubMed ID: 25623482 [TBL] [Abstract][Full Text] [Related]
19. Impact of Serum Albumin Levels on Contrast-Induced Acute Kidney Injury in Patients With Acute Coronary Syndromes Treated With Percutaneous Coronary Intervention. Murat SN; Kurtul A; Yarlioglues M Angiology; 2015 Sep; 66(8):732-7. PubMed ID: 25260710 [TBL] [Abstract][Full Text] [Related]